Waters stock is trading -13.77% below its average target price of $348.65 after marking a 2.7% during today's afternoon session. Analysts are giving the large-cap Medical Specialities company an average rating of hold and target prices ranging from $330.0 to $376.0 per share.
The stock has an average amount of shares sold short at 5.1%, and a short ratio of 6.47. The company's insiders own 0.35% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 91.4% of Waters's shares being owned by this investor type.
Institutions Invested in Waters
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2022-12-31 | Vanguard Group, Inc. (The) | 12% | 6,803,307 | $2,045,346,316 |
| 2022-12-31 | Blackrock Inc. | 11% | 6,587,122 | $1,980,352,454 |
| 2022-12-31 | Fundsmith LLP | 6% | 3,689,697 | $1,109,270,560 |
| 2022-12-31 | Bank Of New York Mellon Corporation | 6% | 3,488,744 | $1,048,856,047 |
| 2022-12-31 | Massachusetts Financial Services Co. | 4% | 2,656,408 | $798,622,540 |
| 2022-12-31 | State Street Corporation | 4% | 2,626,546 | $789,644,827 |
| 2022-12-31 | Geode Capital Management, LLC | 2% | 1,196,875 | $359,828,517 |
| 2022-12-31 | Wellington Management Group, LLP | 2% | 1,101,566 | $331,174,818 |
| 2022-12-31 | Fundsmith Investment Services Ltd. | 1% | 835,238 | $251,105,964 |
| 2022-12-31 | Morgan Stanley | 1% | 802,584 | $241,288,865 |
